A research team from the Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has developed an innovative AI-based cardiovascular risk prediction tool, called CardiOmicScore. With a single blood test, the system can accurately forecast the future risk of six major cardiovascular diseases (CVDs): coronary artery disease, stroke, heart failure, atrial fibrillation, peripheral artery disease and venous thromboembolism. It can also provide early warning signals up to 15 years before clinical onset. The findings were published in Nature Communications.

Medical imaging is important in healthcare; however, its overutilization can contribute to resource wastage and can cause harm to patients. While various guidelines are available for its appropriate utilization, their adoption remains a challenge. Now, a new study in Intelligent Medicine finds that domain-specific adaptation may help improve AI-assisted imaging recommendations, pointing to a new direction for value-based clinical decision support.

Australia’s new ban on social media for under-16s should be judge on much more than whether adolescents stay offline, researchers say.

Experts from Flinders University say success of the policy should be measured by its impact on young people’s mental health, school performance, digital literacy, and how they spend their time outside of social media.

Australian researchers have unlocked the possibility of creating smart wound dressings that enable real-time monitoring while also delivering healing agents in one simple, scalable platform.   

A new Genomic Press Interview published in Brain Medicine profiles Dr. Christian Cazares, a postdoctoral fellow at the University of California, San Diego, who grew up in Calexico, California, a US-Mexico border town where over eighty percent of his schoolmates, including himself, qualified for the free lunch program. The interview reveals how financial hardship, language barriers, and a nephew's autism diagnosis shaped both the scientist and the science. Dr. Cazares discusses his nonprofit Colors of the Brain, his successful campaign to remove the GRE from graduate admissions at UCSD, and his research developing electrophysiological biomarkers for neurodevelopmental disorders, including autism and Rett syndrome, that could reach families too far from major medical centers.

In a Genomic Press Interview published in Brain Medicine, Dr. Gabriella Gobbi, Professor of Psychiatry at McGill University, Canada Research Chair (Tier 1) in Therapeutics for Mental Health, and President-Elect of the Collegium Internationale of Neuropsychopharmacology (CINP), delivers a pointed warning: the greatest threat to drug discovery is not scientific failure but a financing system that abandons effective, affordable treatments whenever they cannot promise sufficient returns to investors. Across a career that began in central Italy and moved through Sardinia and Montreal, Dr. Gobbi has generated landmark research linking adolescent cannabis exposure to depression, identified novel melatonin receptor mechanisms in sleep and pain, and launched psychedelic neuroscience before it became fashionable. The interview reveals a scientist whose best questions have always begun at the bedside, and whose most urgent fears concern the structures that stand between discovery and patients.

In a wide-ranging interview published in Brain Medicine, Dr. Mary L. Phillips, Pittsburgh Foundation-Emmerling Endowed Chair and Distinguished Professor of Psychiatry at the University of Pittsburgh, describes a career built on one stubborn conviction: that the emotional storms of bipolar disorder leave traceable fingerprints in neural circuitry, and that those fingerprints can be read before the storm arrives. Elected to the National Academy of Medicine in 2024 and recipient of the Society of Biological Psychiatry Gold Medal Award that same year, Dr. Phillips discusses the mentors who shaped her, her translational agenda for developing circuit-level biomarkers to identify at-risk youth, and the frustration that propelled her from clinical observation toward precision psychiatry. She also reveals that her greatest fear is boredom, her greatest extravagance is a 2003 red Ford Thunderbird, and her philosophy fits seven words: goals and routes, never confuse the two.